Opsonins: their function, identity, and clinical significance.

The phagocytic process is composed of four interrelated phases: chemotaxis,opsonization, ingestion, and digestion. The function of opsonins is to react with bacteria and make them more susceptible to ingestion by phagocytes. Opsonization of bacteria may occur by three different mechanisms. First, specific antibody alone may act as an opsonin. Specific antibody may also act as an opsonin in concert with complement, by activating C3 via the classic pathway of C1, C4, and C2. Finally, there is a nonspecific mechanism of opsonization present in nonimmune animals called the heat-labile opsonin system. In the heat-labile opsonin system, 7S immunoglobulin from nonimmune animals activates C3 via an alternate pathway distinct from C1, C4, and C2. These different mechanisms may operate concurrently in vivo, but one mechanism may be favored over another depending on the type of organism, the stage of the infection, and the presence or absence of specific antibody. There are a number of different clinical situations in which an increased susceptibility to infection is associated with decreased serum opsonizing activity. These situations serve to illustrate the important role opsonins play in the host's resistance to infection.

[1]  J. Enders,et al.  AN ANALYSIS OF THE OPSONIC AND TROPIC ACTION OF NORMAL AND IMMUNE SERA BASED ON EXPERIMENTS WITH THE PNEUMOCOCCUS , 1933, The Journal of experimental medicine.

[2]  Michael W. Miller,et al.  A FAMILIAL, PLASMA-ASSOCIATED DEFECT OF PHAGOCYTOSIS: A New Cause of Recurrent Bacterial Infections , 1968 .

[3]  Wood Wb Studies on the cellular immunology of acute bacterial infections. , 1951 .

[4]  H. Jasin,et al.  Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation. , 1972, Journal of immunology.

[5]  M. Mayer,et al.  An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Wright,et al.  An experimental investigation of the rôle of the blood fluids in connection with phagocytosis , 1904, Proceedings of the Royal Society of London.

[7]  H. Eichenwald,et al.  Leukocyte function and the development of opsonic and complement activity in the neonate. , 1971, American journal of diseases of children.

[8]  J. Robbins,et al.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT γM- AND γG-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES , 1965, The Journal of experimental medicine.

[9]  D. Horwitz,et al.  Use of leukocyte chemotaxis in vitro to assay mediators generated by immune reactions. I. Quantitation of mononuclear and polymorphonuclear leukocyte chemotaxis with polycarbonate (nuclepore) filters. , 1971, Journal of immunology.

[10]  M. Miller,et al.  Fatal familial Leiner's disease: a deficiency of the opsonic activity of serum complement. , 1972, Pediatrics.

[11]  W. Wood,et al.  Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5. , 1969 .

[12]  W. Wood,et al.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA , 1946, The Journal of experimental medicine.

[13]  H. Müller-Eberhard,et al.  Further studies on the chemotactic factor of complement and its formation in vivo. , 1966, Immunology.

[14]  E. Stiehm,et al.  Impaired opsonic activity but normal phagocytosis in low-birth-weight infants. , 1969, The New England journal of medicine.

[15]  F. Rosen,et al.  Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. , 1970, The Journal of clinical investigation.

[16]  A. Wardlaw,et al.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. , 1954, Science.

[17]  K. Turner,et al.  Number of Molecules of Antibody Required to Promote Phagocytosis of One Bacterium , 1966, Nature.

[18]  R. Messner,et al.  Phagocytosis in subacute bacterial endocarditis. Localization of the primary opsonic site to Fc fragment. , 1968 .

[19]  R. Snyderman,et al.  Chemotactic and Anaphylatoxic Fragment Cleaved from the Fifth Component of Guinea Pig Complement , 1968, Science.

[20]  J. Robbins,et al.  NORMAL RESPONSE OF SICKLE CELL ANEMIA PATIENTS TO IMMUNIZATION WITH SALMONELLA VACCINES. , 1965, The Journal of pediatrics.

[21]  R. Williams,et al.  Opsonic activity in human serum deficient in C2. , 1972, Journal of immunology.

[22]  L. Minor,et al.  Measurement of the Opsonic Effect of Normal and Immune Sera on the Phagocytosis of Salmonella Typhi by the Reticuloendothelial System , 1961, The Journal of Immunology.

[23]  E. Ellis,et al.  Effect of Antibody upon Clearance of I125-Labelled Pneumococci by the Spleen and Liver , 1967, Pediatric Research.

[24]  Watson Rj,et al.  Pneumococcal Meningitis in Sickle-Cell Anemia. , 1966 .

[25]  R. Messner,et al.  Receptors for human γG Globulin on human neutrophils , 1970 .

[26]  V. Nussenzweig,et al.  RECEPTORS FOR COMPLEMENT ON LEUKOCYTES , 1968, The Journal of experimental medicine.

[27]  W. Wood,et al.  HEAT LABILE OPSONINS TO PNEUMOCOCCUS : I. PARTICIPATION OF COMPLEMENT , 1969 .

[28]  F. Rosen,et al.  Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). , 1970, The New England journal of medicine.

[29]  J. Sanford,et al.  Comparison of the Opsonic Activity of γ-G- and γ-M-Anti-Proteus Globulins , 1967, The Journal of Immunology.

[30]  J. G. Hirsch,et al.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM. , 1964, Journal of immunology.

[31]  F. Rosen,et al.  THE ENHANCEMENT OF BACTERIAL PHAGOCYTOSIS BY SERUM THE ROLE OF COMPLEMENT COMPONENTS AND TWO COFACTORS , 1969 .

[32]  U. Nilsson,et al.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). , 1970, The New England journal of medicine.

[33]  I. Gigli,et al.  The complement system of man. 3. , 1972, The New England journal of medicine.

[34]  Louis Pillemer,et al.  THE PROPERDIN SYSTEM AND IMMUNITY III. THE ZYMOSAN ASSAY OF PROPERDIN , 1956 .

[35]  R. Williams,et al.  Studies on interaction of bacteria, serum factors and polymorphonuclear leukocytes in mothers and newborns. , 1969, Pediatrics.

[36]  J. Winkelstein,et al.  Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease. , 1968, The New England journal of medicine.

[37]  R. P. Spencer,et al.  Functional asplenia in sickle-cell anemia. , 1969, The New England journal of medicine.

[38]  M. Polley,et al.  Human Monocytes: Distinct Receptor Sites for the Third Component of Complement and for Immunoglobulin G , 1968, Science.

[39]  W. Wood,et al.  Heat Labile Opsonins to Pneumococcus , 1972, The Journal of Immunology.